期刊文献+

皮肤脱色剂的研究进展 被引量:3

A Review of Skin Depigmenting Agents
下载PDF
导出
摘要 目的从脱色剂的脱色机制及应用角度对近年来的脱色剂研究新进展进行综述。方法以生物及天然来源的化学脱色剂中常用的脱色剂为例介绍了两大类型脱色剂的脱色机制和应用。结果这些脱色剂都能抑制黑色素合成,均为临床可选药物,但有待进一步临床试验以评价它们的安全性。结论为各种脱色剂或增白剂制定安全的使用标准提供依据。 OBJECTIVE The review reveals the mechanism and clinical application of depigmenting agents which have been published recently. METHODS Taking the depigmenting agents usually used which are derived from biological and natural chemical depigmenting agents for example, the mechanism and clinical application of two kinds of depigmenting agents were introduced. RESULTS These depigmenting agents can inhibit synthesis of melanin, therefore, can be used clinically, however, further clinical experiment is needed to assess their security. CONCLUSION It can be provided to assess their safety and efficacy as the criterion.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2008年第5期397-400,共4页 Chinese Journal of Modern Applied Pharmacy
基金 “十一五”国家科技支撑计划课题(No.2006BAK10B09)
关键词 脱色剂 酪氨酸酶 黑色素 depigmenting agent tyrosinase melanin
  • 相关文献

参考文献18

  • 1PARVEZ S, KANG M K, CHUNG H S, et al. Survey and Mechanism of Skin Depigmenting and Lightening Agents [ J ]. Phytother Res,2006,20( 11 ) : 921-934.
  • 2SOLANO F,BRIGANTI S, PICARDO M,et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects [J]. Pigment Cell Res,2006,19 ( 6 ) :550-571.
  • 3KIM D S, PARK S H, KWON S B, et al. Effects of Lysophosphatidic acid on melanogenesis [ J ]. Chem Phys Lipids, 2004, 127 (2): 199-206.
  • 4KIM D S,PARK S H, KWON S B, et al. Sphingosytphosphorylcholine-induced ERK activetion inhibits melanin synthesis in human melanocytes. Pigment [ J]. Cell Res, 2006, 19 ( 2 ) : 146- 153.
  • 5ANDO H,FUNASAKA Y,OKA M,et al. Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids in melanogenesis [ J ]. J Lipids Res, 1999,40 ( 7 ) : 1312- 1316.
  • 6ANDO H, WEN Z M, KIM H Y,et al. Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitin-proteasome pathway[J]. Biochem J, 2006, 394 (1):43-50.
  • 7SANG S,HOU Z,LAMBERT J D,et al. Redox properties of tea polyphenols and related biological activities [ J ]. Antioxid Redox Signal,2005,7 (11-12) : 1704-1714.
  • 8BRIGANTI S, CAMERA E, PICARDO M. Chemical and Instrumental approaches to treat hyperpigmentation [ J]. Pigment Cell Res,2003,16 (2) : 101-110.
  • 9BOISSY R E, VISSCHER M, DELONG M A. DeoxyArbutin: a novel reversible tyrosinaseinhibitor with effective in vivo skin lightening potency [ J ]. Exp Dermatol,2005,14 ( 8 ) :601 - 608.
  • 10HA T J,YANG M S, JANG D S,et al, Inhibitory activities of flavanone derivatives isolated from Sophora flavescens for melanogenesis[ J]. Bull Korean Chem Soc,2001,22( 1 ) :97-99.

同被引文献28

  • 1张春香,尹鸿萍,王旻.几种美白活性物质对酪氨酸酶活性的体外抑制作用及细胞毒性[J].中国生化药物杂志,2005,26(2):72-75. 被引量:17
  • 2张汝芝,朱文元.皮肤脱色剂的研究进展[J].临床皮肤科杂志,2006,35(4):264-266. 被引量:8
  • 3方晶,朱文元,张美华.橙皮苷对中波紫外线诱导豚鼠色素沉着抑制作用的研究[J].临床皮肤科杂志,2007,36(3):141-144. 被引量:13
  • 4国家食品药品监督管理局.中药、天然药物刺激性和溶血性研究的技术指导原则[M].北京:中国医药科技出版社,2005:14-15.
  • 5国家食品药品监督管理局.中药、天然药物免疫毒性(过敏性、光过敏反应)研究的技术指导原则[M].北京:中国医药科技出版社,2005:12-13.
  • 6Pinnell SR.Cutaneous photodamage,oxidative stress,and topical antioxidant protection[J].J Am Acad Dermatol,2003,48(1):1-19.
  • 7Lin YH,Yang YH,Wu SM.Experimental design and capillary electrophoresis for simultaneous analysis of arbutin,kojic acid and hydroquinone in cosmetics[J].J Pharm Biomed Anal,2007,44(1):279-282.
  • 8Gupta AK,Gover MD,Nouri K,et al.The treatment of melasma:a review of clinical trials[J].J Am Acad Dermatol,2006,55(6):1048 -1065.
  • 9Masse MO,Duvallet V,Borremans M,et al.Identification and quantitative analysis of kojic acid and arbutine in skin-whitening cosmetics[J].Int J Cosmet Sci,2001,23(4):219-232.
  • 10Noh JM,Kwak SY,Kim DH,et al.Kojic acid-tripeptide amide as a new tyrosinase inhibitor[J].Biopolymers,2007,88(2):300-307.

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部